Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Operating Segments (Tables)

Note 10 - Operating Segments (Tables)

6 Months Ended

Jun. 30, 2016

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Treatment				Services				Medical				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	7,985			$	6,824				—			$	14,809			$	—			$	14,809
Intercompany revenues			6				10				—				16				—				—
Gross profit			582				1,234				—				1,816				—				1,816
Research and development			120				7				416				543				11				554
Interest income			2				—				—				2				29				31
Interest expense			(14	)			—				—				(14	)			(94	)			(108	)
Interest expense-financing fees			—				—				—				—				(29	)			(29	)
Depreciation and amortization			705				160				—				865				47				912
Segment (loss) income before income taxes			(10,557	)	(2)		1,046				(416	)			(9,927	)			(1,374	)			(11,301	)
Income tax (benefit) expense			(3,167	)	(2)		—				—				(3,167	)			—				(3,167	)
Segment (loss) income			(7,390	)			1,046				(416	)			(6,760	)			(1,374	)			(8,134	)
Expenditures for segment assets			16				4				—				20				—				20

		Treatment				Services				Medical				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	11,087			$	5,267				—			$	16,354			$	—			$	16,354
Intercompany revenues			1				6				—				7				—				—
Gross profit			3,335				697				—				4,032				—				4,032
Research and development			55				—				432				487				2				489
Interest income			1				—				—				1				10				11
Interest expense			(11	)			—				—				(11	)			(129	)			(140	)
Interest expense-financing fees			—				—				—				—				(56	)			(56	)
Depreciation and amortization			743				190				—				933				10				943
Segment income (loss) before income taxes			2,294				60				(432	)			1,922				(1,479	)			443
Income tax expense			36				—				—				36				—				36
Segment income (loss)			2,258				60				(432	)			1,886				(1,479	)			407
Expenditures for segment assets			138				—				—				138				6				144

		Treatment				Services				Medical				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	15,189			$	9,658				—			$	24,847			$	—			$	24,847
Intercompany revenues			10				15				—				25				—				—
Gross profit			444				1,406				—				1,850				—				1,850
Research and development			226				33				854				1,113				15				1,128
Interest income			2				—				—				2				45				47
Interest expense			(16	)			—				—				(16	)			(260	)			(276	)
Interest expense-financing fees			—				—				—				—				(85	)			(85	)
Depreciation and amortization			1,418				321				—				1,739				57				1,796
Segment (loss) income before income taxes			(11,805	) (2)			322				(854	)			(12,337	)			(2,773	)			(15,110	)
Income tax (benefit) expense			(3,130	) (2)			—				—				(3,130	)			—				(3,130	)
Segment (loss) income			(8,675	)			322				(854	)			(9,207	)			(2,773	)			(11,980	)
Expenditures for segment assets			23				4				1				28				—				28

		Treatment				Services				Medical				Segments Total				Corporate (1)				Consolidated Total
Revenue from external customers		$	20,836			$	9,119				—			$	29,955			$	—			$	29,955
Intercompany revenues			2				15				—				17				—				—
Gross profit			4,570				940				—				5,510				—				5,510
Research and development			89				—				827				916				2				918
Interest income			2				—				—				2				18				20
Interest expense			(34	)			—				—				(34	)			(233	)			(267	)
Interest expense-financing fees			(2	)			—				—				(2	)			(113	)			(115	)
Depreciation and amortization			1,507				380				—				1,887				22				1,909
Segment income (loss) before income taxes			2,514				(241	)			(827	)			1,446				(2,981	)			(1,535	)
Income tax expense			71				—				—				71				—				71
Segment income (loss)			2,443				(241	)			(827	)			1,375				(2,981	)			(1,606	)
Expenditures for segment assets			244				13				—				257				8				265